Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2007-01-05

FDA Approved: XENICAL — Supplemental Application (H2-Pharma LLC)

View source ↗

Summary

The FDA approved a supplemental application for XENICAL (orlistat) submitted by H2-Pharma LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • XENICAL (orlistat)

Snippet

SUPPL AP for XENICAL (ORLISTAT)